Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a new 'Locations' section with California listed as a study site; the old 'California Locations' heading was removed and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:32:41.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now lists related topics 'Ovarian cancer' and 'MedlinePlus Genetics' in the related topics section. This addition provides cross-references to disease information.
    Difference
    0.2%
    Check dated 2025-12-16T04:44:54.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed related topics links for Ovarian cancer and MedlinePlus Genetics from the Related Topics section.
    Difference
    0.2%
    Check dated 2025-12-09T01:18:32.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Ovarian cancer and MedlinePlus Genetics related topics were added as related topics on the page.
    Difference
    0.2%
    Check dated 2025-12-01T23:10:06.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.2 appears and ovarian cancer-related topics, MedlinePlus Genetics, and Revision: v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-24T20:53:08.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The funding-warning notice about government operating status was removed from the study page, a non-substantive site-wide notification. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:11:23.000Z thumbnail image

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.